HBCP · Home Bancorp, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| 11% of total assets | 11% | Q2 2026 | — |
| 2Q 2026 WAR | -6.46% | Q2 2026 | — |
| 46% of loan portfolio is variable | 46% | Q2 2026 | — |
| Acquired loans | 270.17M | Jun-26 YTD | — |
| Acquired NPAs | 8.2M | Jun-26 YTD | — |
| Acquired past due loans | 9.29M | Jun-26 YTD | — |
| ALL / Total Loans | 1.22% | Q2 2026 | — |
| Allowance for credit losses to total loans | 1.28% | Three Months Ended 6/30/2026 | — |
| Allowance for loan losses to nonperforming loans | 128.65% | Three Months Ended 6/30/2026 | — |
| Allowance for loan losses to total loans | 1.22% | Three Months Ended 6/30/2026 | — |
| Annualized YTD net loan charge-offs to average loans | -0.06% | Three Months Ended 6/30/2026 | — |
| Average assets | 3.55B | Jun-26 YTD | — |
| Average assets excluding PPP loans non-GAAP | 3.55B | Jun-26 YTD | — |
| Average deposit size | $37,534 | Q2 2026 | — |
| Average loan yield | 6.46% | Q2 2026 | — |
|
|
|||
| Book value | $434.16M | Q2 2026 | — |
| Book value per share | $57.63 | 2Q2026 | — |
| Cash dividend of $0.32 per share payable on August 14, 2026 | $0.32 | Q2 2026 | — |
| Common Equity Tier 1 capital non-GAAP | 13.8% | Q2 2026 | — |
| Core deposits | 2.3B | Q2 2026 | — |
|
|
|||
| Core pre-provision net income non-GAAP | $12.23M | 2Q 2026 | — |
| Core pre-provision net income (YTD) non-GAAP | 24.35M | Jun-26 YTD | — |
| Cost of total deposits for the quarter ended June 2026 | 1.66% | Q2 2026 | — |
| Coverage of Uninsured Deposits | 174% | Q2 2026 | — |
| Efficiency Ratio non-GAAP | 70% | Q2 2026 | — |
| Houston market annualized growth rate YTD | -9% | YTD 2026 | — |
| Investment Portfolio effective duration | 3.4 | Q2 2026 | — |
| Loan portfolio effective duration | 1.7 | Q2 2026 | — |
| Loan/Deposit ratio | 90.6% | 2Q 2026 | — |
| Loans | 2.8B | Q2 2026 | — |
|
|
|||
| LOC Utilization Rate | 48% | Q2 2026 | — |
| Net interest margin | 4.24% | Q2 2026 | — |
|
|
|||
| Net interest margin (TE) non-GAAP | 4.2% | Six Months Ended 6/30/2026 | — |
| Net interest spread (TE) non-GAAP | 3.44% | Six Months Ended 6/30/2026 | — |
| New Share Repurchase Plan approved | 400,000 | Q2 2026 | — |
| Non-GAAP noninterest expense non-GAAP | 47.49M | Jun-26 YTD | — |
| Non-GAAP noninterest income non-GAAP | 7.66M | Jun-26 YTD | — |
| Non-GAAP tangible book value per share non-GAAP | $47.02 | Q2 2026 | — |
|
|
|||
| Non-GAAP tangible net income non-GAAP | 11.78M | 2Q 2026 | — |
| Non-GAAP tangible shareholders' equity non-GAAP | 369.94M | 2Q 2026 | — |
| Non-interest bearing deposit composition | 27% | Q2 2026 | — |
| Nonperforming assets | $39.2M | Q2 2026 | — |
|
|
|||
| Nonperforming assets (% of total assets) | 1.09% | Q2 2026 | — |
| Nonperforming loans to total loans | 0.95% | Three Months Ended 6/30/2026 | — |
| Originated loans | 2.51B | Jun-26 YTD | — |
| Originated NPAs | 31.02M | Jun-26 YTD | — |
| Originated past due loans | 16.01M | Jun-26 YTD | — |
| Price / tangible book value per share non-GAAP | 146% | 2Q 2026 | — |
| Q2 yield | 2.7% | Q2 2026 | — |
| ROATCE non-GAAP | 12.9% | 2Q 2026 | — |
| Shares Outstanding | 7,868,139 | 2Q2026 | — |
| shares remaining in current plan | 383,170 | Q2 2026 | — |
| Shares repurchased since 2019 | 17% | Q2 2026 | — |
| Tangible book value non-GAAP | $47.02 | 2Q 2026 | — |
| Tangible book value per share non-GAAP | $47.02 | Q2 2026 | — |
| TBV / share CAGR since 2019 non-GAAP | 8.8% | Q2 2026 | — |
| TCE Ratio | 10.5% | 2Q 2026 | — |
| Tier 1 leverage capital | 12.1% | Q2 2026 | — |
| Tier 1 risk based capital non-GAAP | 13.8% | Q2 2026 | — |
| Total loans | 2.78B | Jun-26 YTD | — |
| Total NPAs | 39.21M | Jun-26 YTD | — |
| Total past due loans | 25.3M | Jun-26 YTD | — |
| Total risk based capital | 15.6% | Q2 2026 | — |
| Uninsured Deposits | $776M | Q2 2026 | — |
| YTD 2026 annualized growth rate | -3% | YTD 2026 | — |
| Allowance for loan losses | $33.7M | the first quarter of 2026 | — |
| Net loan charge-offs | $384,000 | the first quarter of 2026 | — |
| Provision to the allowance for loan losses | $922,000 | the first quarter of 2026 | — |
| Non-GAAP return on average tangible common equity non-GAAP | 13.31% | Q4 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Banks - Regional — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HBCP
this stock
Home Bancorp, Inc.
|
$542.45M | +20.6% | — | 11.5 | 4.0% |
|
MFG
Mizuho Financial Group Inc
|
$124.83B | +40.4% | — | — | 0.1% |
|
HDB
Hdfc Bank Ltd
|
$121.52B | -35.4% | +15.2% | — | 0.5% |
|
IBN
Icici Bank Ltd
|
$105.45B | +0.4% | — | — | 0.5% |
|
CIXPF
CaixaBank/ADR
|
$100.59B | +19.4% | — | — | 0.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HBCP | -3.1% | -0.7% | +15.2% | -2.3% | +20.6% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | -1.8% | -4.3% | +3.6% | -4.8% | +8.3% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.